Foreign Filer Report • Apr 3, 2014
Foreign Filer Report
Open in ViewerOpens in native device viewer
_________ false
C002����� ��"�2PublicKAMADA LTD9024Corporation no: 511524605Stock Exchange/Market: -11934380Sapir 7 P.O.B 4081 , Ness-Ziona 74036 , ISRAEL ,Tel: 08-9406472 , Fax: 08-9406473E.mail address: [email protected] via MAGNA: 03/04/2014 Time of broadcast: 13:27 13:26:24
| Company site: | www.kamada.com |
Reference: 2014-02-037731
| Israel Securities Authority | Tel Aviv Stock Exchange | |||||
| www.isa.gov.il | www.tase.co.il |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on Kamada Announces U.S. Proof-of-Concept Study with Glassia for Graft-Versus-Host Disease |
| KMDA_Form_6K_GVHD_trial_in_the_US_April_2014_isa.pdf |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |
| Previous names of reporting entity: |
| Date of revision of form structure: 02/03/2014 |
| - - - |
| Name of the Signatory: : Cohen Liat , Position of Signatory in the reporting corporation: Company Controller , Name of Employer Company: . |
| Sapir Telephone: 08-9913168 , Facsimile: 08-9912183 , E-mail: [email protected] 1 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.